Trial Profile
In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster, Chiesi) in healthy volunteers, asthmatic and COPD patients.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Aug 2014
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici
- 29 Aug 2011 New trial record